Skip to content
HowShorted

ADIAL PHARMACEUTICALS, INC. short interest in 2022

In 2022, ADIAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 3.91% of shares outstanding on 14 Jan 2022 to 0.48% on 30 Dec 2022, a change of -3.43 percentage points. The year's high was 4.17% on 15 Mar 2022 and its low 0.48% on 30 Nov 2022, averaging 2.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.70 days on 31 Mar 2022. Full history: ADIAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ADIAL PHARMACEUTICALS, INC. in 2022

2022 in figures

Start of year
3.91% (14 Jan 2022)
End of year
0.48% (30 Dec 2022)
Change
-3.43 pp
High
4.17% (15 Mar 2022)
Low
0.48% (30 Nov 2022)
Average
2.34%
Highest days to cover
12.70 (31 Mar 2022)
SEC filings marked
7

Every report in 2022

ADIAL PHARMACEUTICALS, INC. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20223.91%6.40
31 Jan 20223.56%5.65
15 Feb 20223.64%6.21
28 Feb 20223.94%8.17
15 Mar 20224.17%7.72
31 Mar 20223.58%12.7010-K filed
14 Apr 20223.95%5.19
29 Apr 20223.63%7.80
13 May 20223.65%7.29
31 May 20223.47%6.7510-Q filed, results (8-K)
15 Jun 20223.37%2.46
30 Jun 20222.44%1.42
15 Jul 20222.88%1.00
29 Jul 20222.70%1.00
15 Aug 20221.18%1.0010-Q filed
31 Aug 20221.30%1.38results (8-K)
15 Sep 20220.95%1.00
30 Sep 20220.68%1.24
14 Oct 20220.62%2.17
31 Oct 20220.57%1.49
15 Nov 20220.50%1.3410-Q filed, results (8-K)
30 Nov 20220.48%2.13
15 Dec 20220.50%1.02
30 Dec 20220.48%1.00

See also: ADIAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.